Literature DB >> 21979990

Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.

Andrea Barbieri1, Francesca Bursi, Francesca Mantovani, Chiara Valenti, Michele Quaglia, Elena Berti, Massimiliano Marino, Maria Grazia Modena.   

Abstract

AIMS: Despite the American Society of Echocardiography (ASE)/European Association of Echocardiography (EAE) recommended the use of left ventricular (LV) mass to diagnose left ventricular hypertrophy (LVH), several laboratories continue to use only the septal thickness by M-mode because it appears easier to measure. Aim of the study was to investigate the discrepancy between the categorization of LVH severity based on measurement of septal thickness and indexed LV mass and the relative prognostic utility of these two methods. METHODS AND
RESULTS: Observational cohort study. Unselected adults (>18 years) referred to the echocardiography laboratory for any indication had septal thickness and LV mass measured by the ASE/EAE formula using LV linear dimensions indexed to body surface area. LVH was categorized as absent, mild, moderate, and severe according to the ASE/EAE guideline sex-specific categorization cut-offs for septal thickness and LV mass. Follow-up for death was obtained from the national death index. A total of 2545 subjects (mean age 61.9 ± 15.8, 53% women, mean diastolic septal thickness 10.3 ± 2.2 mm, and mean indexed LV mass 107.5 ± 37.3 g/m(2)) were enrolled. Agreement between the two methods in classifying LVH degree across the four categories was 52.6% (Kappa = 0.29, 95% confidence interval (CI): 0.26-0.32, P < 0.001). Of the 2513 subjects without severely thickened septum, 472 (18.9%) had severely abnormal indexed LV mass. Vice versa, of the 2045 individuals without severely abnormal indexed LV mass, only 4 (0.1%) were classified as severe LVH by septal thickness. After a mean follow-up of 2.5 ± 1.2 years 121 (4.7%) deaths occurred. Using indexed LV mass partition values there was a graded association between LVH degree and survival. Compared with patients with normal indexed LV mass, the adjusted hazard ratio (HR) for death from all causes was 2.17 for mild (95% CI: 1.23-3.81, P = 0.007), 3.04 for moderate (95% CI: 1.76-5.24, P < 0.001), and 3.81 for severe (95% CI: 2.43-5.97, P < 0.001) LVH by indexed LV mass. The area under the receiver-operator characteristic (ROC) curve for the four degrees of LVH by indexed LV mass was superior [area under the curve (AUC) = 0.66] to that of the septal thickness partition values (AUC = 0.58, P = 0.0004).
CONCLUSION: In a large cohort study of unselected adult outpatients referred to the echocardiography laboratory, the measurements of indexed LV mass applying the ASE/EAE recommended cut-offs yielded remarkable discrepancy in the diagnosis of LVH severity and offered prognostic information beyond that provided by septal thickness only criteria.

Entities:  

Mesh:

Year:  2011        PMID: 21979990     DOI: 10.1093/ejechocard/jer176

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  19 in total

1.  Echocardiography in hypertension: a call for standardization from the Working Group on Heart and Hypertension of the Italian Society of Hypertension.

Authors:  Cesare Cuspidi; Maria Lorenza Muiesan; Nicola De Luca; Massimo Salvetti; Enrico Agabiti-Rosei; Giuseppe Schillaci
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-08

Review 2.  Cardiac aging phenomenon and its clinical features by echocardiography.

Authors:  Boqing Xu; Masao Daimon
Journal:  J Echocardiogr       Date:  2016-05-12

3.  Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.

Authors:  LaTonya J Hickson; Sara M Negrotto; Macaulay Onuigbo; Christopher G Scott; Andrew D Rule; Suzanne M Norby; Robert C Albright; Edward T Casey; John J Dillon; Patricia A Pellikka; Sorin V Pislaru; Patricia J M Best; Hector R Villarraga; Grace Lin; Amy W Williams; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2016-03-15       Impact factor: 24.094

Review 4.  Hemodynamic characteristics and early warnings in very old patients.

Authors:  Hui Lian; Xin Ding; Hongmin Zhang; Dawei Liu; Xiaoting Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  Black-white Differences in Left Ventricular Hypertrophy Rates Among Young Adults with Ischemic Stroke.

Authors:  Yan Hou; Kathleen A Ryan; Carolyn A Cronin; Elizabeth M Aradine; John W Cole; Seemant Chaturvedi; Marcella A Wozniak; Prachi Mehndiratta; Michael S Phipps; Karen L Yarbrough; Mohammad Yousaf; Steven J Kittner
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-07-04       Impact factor: 2.677

6.  Increased susceptibility of spontaneously hypertensive rats to ventricular tachyarrhythmias in early hypertension.

Authors:  Thao P Nguyen; Ali A Sovari; Arash Pezhouman; Shankar Iyer; Hong Cao; Christopher Y Ko; Aneesh Bapat; Nooshin Vahdani; Mostafa Ghanim; Michael C Fishbein; Hrayr S Karagueuzian
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

7.  Solitary accessory and papillary muscle hypertrophy manifested as dynamic mid-wall obstruction and symptomatic heart failure: diagnostic feasibility by multi-modality imaging.

Authors:  Kuo-Tzu Sung; Chun-Ho Yun; Charles Jia-Yin Hou; Chung-Lieh Hung
Journal:  BMC Cardiovasc Disord       Date:  2014-03-10       Impact factor: 2.298

8.  The relationship between left ventricular mass index and body composition in new-diagnosed hypertensive patients.

Authors:  Sebnem Karakan; Bekir Inan
Journal:  Clin Hypertens       Date:  2015-12-12

Review 9.  Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review.

Authors:  Maaike Alkema; Ernest Spitzer; Osama I I Soliman; Christian Loewe
Journal:  J Cardiovasc Ultrasound       Date:  2016-12-28

10.  Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis.

Authors:  Helen M Parry; Louise A Donnelly; Natalie Van Zuydam; Alexander Sf Doney; Douglas Hj Elder; Andrew D Morris; Alan D Struthers; Colin Na Palmer; Chim C Lang
Journal:  Cardiovasc Diabetol       Date:  2013-07-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.